2017-18 Annual Report
|Complete document||PDF 3MB||DOCX 3MB|
|Transmittal letter from FIRB Chair to Treasurer||PDF 138KB|
|Executive summary||PDF 140KB|
|Chapter 1: The Foreign Investment Review Board||PDF 518KB|
|Chapter 2: The Foreign Investment Framework||PDF 357KB|
|Chapter 3: Applications Data||PDF 800KB|
|Chapter 4: Compliance||PDF 319KB|
|Appendix A: FIRB Meetings during 2017-18||PDF 219KB|
|Appendix B: Methodological and Data Caveats||PDF 252KB|
|Appendix C: Examination and Approval Process||PDF 522KB|
|Appendix D: Glossary||PDF 231KB|
In 2017-18, the Foreign Investment Review Board (FIRB) reviewed a significant number of high profile foreign investment applications, including the acquisition of the Whyalla steelworks and the acquisition of Australia’s largest diagnostic imaging provider, I-MED Radiology Network. Over 11,000 proposed transactions were approved representing potential investment of $163.1 billion.
The services sector attracted the highest value of approved investment, with the value of approvals in health care doubling. The value of residential real estate approvals declined from $30.0 billion in 2016-17 to $12.5 billion in 2017-18, reflecting a slowing in foreign demand for residential real estate.
For the first time since 2012–13, the United States surpassed China as the largest source country for approved proposed investment due to an increase in United States approvals and a decline in Chinese approvals. The United States recorded an increase in approved investment from $26.5 billion in 2016-17 to $36.5 billion in 2017-18, with significant increases in real estate and the manufacturing, electricity and gas sector.